Clinical decision support tool and rapid point-of-care platform for determining disease severity in patients with COVID-19-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical decision support tool and rapid point-of-care platform for determining disease severity in patients with COVID-19

Published:2020 Issue:12 Volume:20 Page:2075-2085
ISSN:1473-0197
Container-title:Lab on a Chip
language:en
Short-container-title:Lab Chip

Author:

McRae Michael P.¹²³⁴⁵^ORCID,Simmons Glennon W.¹²³⁴⁵,Christodoulides Nicolaos J.¹²³⁴⁵,Lu Zhibing⁶⁷⁸⁹,Kang Stella K.¹⁰¹¹⁴⁵^ORCID,Fenyo David¹²¹³⁴⁵,Alcorn Timothy¹⁴¹⁵⁵,Dapkins Isaac P.¹⁶¹³⁴⁵,Sharif Iman¹⁷¹³⁴⁵,Vurmaz Deniz¹⁸¹⁹³⁴⁵,Modak Sayli S.¹²³⁴⁵,Srinivasan Kritika²⁰¹³³⁴⁵,Warhadpande Shruti¹²³⁴⁵,Shrivastav Ravi¹²³⁴⁵,McDevitt John T.¹²³⁴⁵^ORCID

Affiliation:

1. Department of Biomaterials

2. Bioengineering Institute

3. New York University

4. New York

5. USA

6. Department of Cardiology

7. Zhongnan Hospital of Wuhan University

8. Wuhan

9. China

10. Departments of Radiology

11. Population Health New York University School of Medicine

12. Department of Biochemistry and Molecular Pharmacology

13. New York University School of Medicine

14. Latham BioPharm Group

15. Cambridge

16. Department of Population Health and Internal Medicine

17. Departments of Pediatrics and Population Health

18. Department of Chemical and Biomolecular Engineering

19. NYU Tandon School of Engineering

20. Departments of Biomaterials, Pathology

Abstract

The COVID-19 Severity Score combines multiplex biomarker measurements and risk factors in a statistical learning algorithm to predict mortality.

Funder

National Institute of Dental and Craniofacial Research

Publisher

Royal Society of Chemistry (RSC)

Subject

Biomedical Engineering,General Chemistry,Biochemistry,Bioengineering

Link

http://pubs.rsc.org/en/content/articlepdf/2020/LC/D0LC00373E

Reference32 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019

2. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

3. Coronavirus Disease 2019 (COVID-19) Situation Report - 75 , World Health Organization

4. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

5. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Laboratory and genetic predictors for severe COVID-19 infection;Pharmacia;2024-04-02

2. Signaling redox probe/DNA aptamer complexes on a new POP/2D WSe2 composite-based immunosensor towards the simultaneous detection of three-protein overexpression as an alternative severe SARS-COV-2 infection diagnosis;Sensors and Actuators B: Chemical;2024-04

3. A brief review of cytology in dentistry;British Dental Journal;2024-02-23

4. Simultaneous Quantitative SARS-CoV-2 Antigen and Host Antibody Detection and Pre-Screening Strategy at the Point of Care;Bioengineering;2023-06-01

5. Computed tomography severity score as a predictor of disease severity and mortality in COVID-19 patients: A systematic review and meta-analysis;Journal of Medical Imaging and Radiation Sciences;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3